| Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681) |
|---|
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/28/2001 | US6281198 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro-[3′,4′:6,7]naphtho[2,3-d][1,3]dioxol-6(5aH)-one compounds |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/23/2001 | WO2001060833A2 Motilide compounds |
| 08/23/2001 | WO2001060832A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
| 08/23/2001 | WO2001060390A1 New toralactone and its derivation and the use of decreasing blood-fat and losing weight |
| 08/23/2001 | US20010016598 Erythromycins and process for their preparation |
| 08/23/2001 | US20010016574 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin |
| 08/23/2001 | CA2399198A1 Motilide compounds |
| 08/22/2001 | EP1125944A1 Pluraflavin and derivatives thereof, process for making them as well as their use |
| 08/22/2001 | EP1124980A2 Method for the production of quercetin and isoquercetin derivatives |
| 08/22/2001 | EP1124968A2 Library of novel "unnatural" natural products |
| 08/22/2001 | EP1124837A2 Novel macrolide antibiotics |
| 08/22/2001 | EP1124836A1 Chromogenic substrates of sialidase and methods of making and using the same |
| 08/22/2001 | EP1124564A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 08/22/2001 | EP1124560A1 Use of antifungal agents for treating scleroses |
| 08/22/2001 | EP1124548A2 Compositions for the treatment and prevention of cardiovascular diseases |
| 08/22/2001 | EP1124528A1 Multivalent macrolide antibiotics |
| 08/22/2001 | CN1309133A Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2000057866A3 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 08/16/2001 | US20010014669 Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | EP1123304A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 08/16/2001 | EP1123096A1 Bioflavonoids as plasma high density lipoprotein level increasing agent |
| 08/16/2001 | EP0888372B1 Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone conjugates |
| 08/16/2001 | CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/15/2001 | CN1308084A Resin adsorption process of preparing sea-buckthorn flavone with sea-buckthorn leaf |
| 08/15/2001 | CN1069647C Compound with broad-spectrum antibacterial action |
| 08/14/2001 | US6274715 Semisynthetic macrolides, useful in bacterial infections treatment and prevention, has less potential for developing resistance, improved or modified profiles of desired gram-negative activity |
| 08/14/2001 | US6274597 Method of enhancing lysosomal α-Galactosidase A |
| 08/14/2001 | US6274560 Incubating diketide with modified polyketide synthase; recovering; genetic engineering |
| 08/08/2001 | EP1122261A2 13 and 14-membered antibacterial macrolides |
| 08/08/2001 | EP1121134A1 Derivatives of erythromycin, clarithromycin, roxithromycin or azithromycin with antibiotic and mucolytic activity |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1069197C Pharmaceutical formulation containing dirithromycin |
| 08/08/2001 | CN1069169C Applying formulations containing glycols and/or glycerides |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271255 Useful as antibacterial and antiprotozoal agents in infections in mammals, fish, and birds |
| 08/07/2001 | US6270768 Azithromycins |
| 08/02/2001 | WO2001055158A1 Azalide antibiotic compositions |
| 08/02/2001 | WO2001054691A1 Nitrate salts of antimicrobial agents |
| 08/02/2001 | CA2397754A1 Nitrate salts of antimicrobial agents |
| 07/31/2001 | US6268489 Azithromycin dihydrate |
| 07/26/2001 | WO1999064040A8 Novel polyene macrolide compounds and uses |
| 07/25/2001 | EP1117671A2 Synthetic method for the preparation of the antineoplastic agent etoposide |
| 07/24/2001 | US6265571 Recovering ivermectin from mixture; obtaining impure ivermectin, loading onto chromatographic column, establish gradient, recover ivermectin |
| 07/24/2001 | CA2261732C Preparation of crystal form ii of clarithromycin |
| 07/24/2001 | CA2026540C Water soluble derivatives of glycoside bioflavonoids, processes for their preparation and related pharmaceutical compositions |
| 07/19/2001 | WO2001051061A1 Derivatives of polyene macrolides and preparation and use thereof |
| 07/19/2001 | WO2001051059A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | CA2397092A1 Processes for preparing clarithromycin polymorphs |
| 07/19/2001 | CA2394833A1 Derivatives of polyene macrolides and preparation and use thereof |
| 07/18/2001 | EP1115732A1 Carbamate and carbazate ketolide antibiotics |
| 07/18/2001 | EP0824539B1 Dialkyltiacumicin compounds |
| 07/17/2001 | US6262030 Erythromycin derivatives |
| 07/17/2001 | US6261816 Culturing recombinant host cells having modified modular polyketide synthase having deactivated ketosynthase catalytic domain which prevents enzyme from using natural starter unit, then optionally recovering modified synthase |
| 07/17/2001 | US6261813 Two step enzymatic acylation |
| 07/12/2001 | WO2001049699A1 Macrolide antiinfective agents |
| 07/12/2001 | WO2001049697A1 Preparation method of azithromycin dihydrate |
| 07/12/2001 | WO2000063361A3 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 07/12/2001 | CA2396426A1 Preparation method of azithromycin dihydrate |
| 07/11/2001 | EP1114826A2 Novel antibacterial and prokinetic macrolides |
| 07/11/2001 | EP1113791A2 Bioflavonoid as blood glucose level lowering agent |
| 07/11/2001 | CN1303389A 3',3'-N-substituted macrolide LHRH antagonists |
| 07/10/2001 | US6258785 Antibiotics as bactericides and antiprotozoa agents |
| 07/05/2001 | WO2001047507A2 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/05/2001 | US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture |
| 07/05/2001 | US20010006944 Treating noninvasive fungus-induced rhinosinusitis by mucoadministering an antifungal agent; culturing noninvasive fungus from a mammalian mucus sample for antigen/antibody production; apparatus for collecting nasal mucus |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/04/2001 | EP1112280A1 Method of preparing form ii crystals of clarithromycin |
| 07/04/2001 | CN1302295A Synthetic methods for polyphenols |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |
| 06/28/2001 | WO2001046211A1 Method for preparing and isolating 9-deoxo-9(z)-hydroxyiminoerythromycin a |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | US20010005715 Comprising the condensation reaction product of an aldose such as glucose and a benzene containing one or more hydroxy, amino, carboxy, or sulfonyl groups; use such as iron, zinc or manganese complex fertilizers for plants |
| 06/27/2001 | EP1110960A1 Apoptosis inducing agents |
| 06/27/2001 | EP1109820A1 Nocathiacin antibiotic derivatives prepared by microbial biotransformation |
| 06/27/2001 | CN1301268A 15-membered lactams ketolides with antibacterial activity |
| 06/21/2001 | WO2001044262A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/21/2001 | WO2001044186A1 Substituted guanidine derivatives |
| 06/21/2001 | WO2001014393A3 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms |
| 06/21/2001 | CA2395555A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/20/2001 | CN1067402C Process for prepn. of podophyllo ethylidene glucoside |
| 06/20/2001 | CN1067401C 5-0-deosaminyl 6-0-methyl erythronolide A derivatives and preparation method therefor |
| 06/19/2001 | US6248905 Oil-solubility; easily permeate into living tissues to release l-ascorbic acid, resulting in an exertion of the physiological action inherent to l-ascorbic acid. |
| 06/19/2001 | US6248719 Tricyclic 3-keto derivatives of 6-O-methylerthromycin |
| 06/14/2001 | WO2001041775A2 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 06/14/2001 | WO2000068413A8 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 06/13/2001 | EP1105402A1 Method for industrial production of diosmin from hesperidin by reaction with iodine and pyridine |
| 06/13/2001 | CN1299368A Improvement in macrolide prodn. |
| 06/13/2001 | CN1067077C Erythromycin derivant and prepn. method and usage of medicine thereof |
| 06/12/2001 | US6245903 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| 06/07/2001 | WO2001040242A2 6-o-methylerythromycin a crystal form iii |
| 06/07/2001 | WO2001040241A2 6-o-alkyl-2-nor-2-substituted ketolide derivatives |
| 06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
| 06/07/2001 | CA2393047A1 6-o-methylerythromycin a crystal form iii |
| 06/06/2001 | EP1104435A2 System and method for visually representing a supply chain |
| 06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
| 06/05/2001 | US6242425 Sinapic acid glycoside intermediates |